Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
CELU Celularity
0.965+0.033+3.54%
Close
02/03 16:00 ET
0.985+0.020+2.03%
Post Mkt Price 02/03 18:38 ET
High
0.989
Open
0.950
Turnover
381.50K
Low
0.931
Pre Close
0.932
Volume
397.09K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Correcting & Replacing -- Celularity Receives Preliminary Assessment of Product Classification and Jurisdiction for Its Investigational Celularity Tendon Wrap (CTW) to Be Regulated as a Device Within U.S. Food and Drug Administration (FDA) Center for Dev
Celularity's Pre-Request for Designation (Pre-RFD) is based on data showing CTW contains 100 percent extracellular matrix Celularity to submit 510(k) pre-market notification to the FDA Center for Devices and
14,759 Shares in Celularity Inc. (NASDAQ:CELU) Acquired by Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC acquired a new position in shares of Celularity Inc. (NASDAQ:CELU – Get Rating) during the 3rd quarter, according to its most recent filing with the Securit
Morgan Stanley Lowers Celularity (NASDAQ:CELU) to Underweight
Morgan Stanley downgraded shares of Celularity (NASDAQ:CELU – Get Rating) from an equal weight rating to an underweight rating in a research note released on Monday morning, MarketBeat Ratings report
Celularity Shares Climb 9.7% on FDA Agreement Over Product Recommendation
By Denny Jacob Celularity Inc. shares climbed 9.7% to $1 in after-hours trading Wednesday after it said the Food and Drug Administration agreed with its recommendation regarding the regulation of its
Celularity Announces FDA Feedback From Pre-RFD for Investigational CTW
Celularity Receives Preliminary Assessment of Product Classification and Jurisdiction for Its Investigational Celularity Tendon Wrap (CTW) to Be Regulated as a Device Within U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Heal
Celularity's Pre-Request for Designation (Pre-RFD) is based on data showing CTW contains 100 percent extracellular matrix Celularity to submit 510(k) pre-market notification to the FDA Center for Devi
Stocks That Hit 52-Week Lows On Tuesday
 Tuesday's session saw 13 companies set new 52-week lows. Things to Consider About Today's 52-Week Lows: Glacier Bancorp (NYSE:GBCI) is the largest company in terms of market cap to set a new 52-we
Celularity (NASDAQ:CELU) Lowered to "Underweight" at Morgan Stanley
Morgan Stanley lowered shares of Celularity (NASDAQ:CELU – Get Rating) from an equal weight rating to an underweight rating in a report released on Monday, MarketBeat reports. Morgan Stanley currentl
HC Wainwright Lowers Price Target on Celularity to $2.50 From $15, Maintains Buy Rating
09:11 AM EST, 01/30/2023 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may co
Celularity Falls as Morgan Stanley Downgrades After Strategic Update
Company Overview
More
GX Acquisition Corp. operates as a blank check company, which focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on August 24, 2018 and is headquartered in New York, NY.
CEO： Dr. Robert J. Hariri, M.D.,PhD
Market： NASDAQ
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet